Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Accounts Payables (2021 - 2024)

Historic Accounts Payables for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to $1669.8 billion.

  • Universe Pharmaceuticals' Accounts Payables rose 116151380.76% to $1669.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1669.8 billion, marking a year-over-year increase of 116151380.76%. This contributed to the annual value of $1669.8 billion for FY2025, which is 116151380.76% up from last year.
  • According to the latest figures from Q3 2025, Universe Pharmaceuticals' Accounts Payables is $1669.8 billion, which was up 116151380.76% from $143.7 million recorded in Q3 2024.
  • Universe Pharmaceuticals' Accounts Payables' 5-year high stood at $1669.8 billion during Q3 2025, with a 5-year trough of $3.1 million in Q3 2022.
  • Its 5-year average for Accounts Payables is $334.3 billion, with a median of $143.7 million in 2024.
  • As far as peak fluctuations go, Universe Pharmaceuticals' Accounts Payables tumbled by 9124.26% in 2024, and later surged by 116151380.76% in 2025.
  • Over the past 5 years, Universe Pharmaceuticals' Accounts Payables (Quarter) stood at $5.3 million in 2021, then tumbled by 42.09% to $3.1 million in 2022, then soared by 53272.89% to $1.6 billion in 2023, then tumbled by 91.24% to $143.7 million in 2024, then surged by 1161513.81% to $1669.8 billion in 2025.
  • Its Accounts Payables was $1669.8 billion in Q3 2025, compared to $143.7 million in Q3 2024 and $1.6 billion in Q3 2023.